Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus, or RSV, in adults 60 years and older, making it the country's first authorized mRNA-based ...

Barclays lowered the firm’s price target on Moderna (MRNA) to $111 from $125 and keeps an Overweight rating on the shares. The company’s Q3 SpikeVax revenue beat estimates and guidance was ...

Cost of sales dropped 77% thanks to well-managed costs and strategic pivots. Moderna reported earnings that exceeded expectations due to effective cost management but still has challenges related ...

Moderna's Q3 Earnings Beat Overshadowed By Vaccine Demand Slowdown And Market Share Concerns, Analysts Warn Moderna's stock faces a decline as analysts lower the price target to $90, citing weaker ...

Health Canada has approved Moderna's mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older — but it won't be available until next year, the company said on Friday.

View upcoming earnings forecasts and in-depth analysis of company forecasts.

In an ambitious move, Moderna has teamed up with OpenAI, the artificial intelligence company behind ChatGPT, to further integrate generative AI (GenAI) across its mRNA drug development and ...

Moderna has said it will open a new R&D and manufacturing facility in the UK which could lead to improved access by NHS patients to mRNA-based vaccines and drug treatments. The facility is the ...

Don’t get me wrong, they are all formed of aluminum ... 12 x 8.5 x 0.4 inches 2.7 pounds MacBook Pro 16-inch (M2 Max) 14 x 9.8 x 0.7 inches 4.8 pounds MacBook Pro 14-inch (M2 Pro) 12.3 x 8.7 ...

In 2023, Apple introduced the 15-inch MacBook Air, which features an expansive 15.3-inch Liquid Retina display, the powerful performance of the M2 chip, up to 18 hours of battery life, and a six ...